查詢結果分析
來源資料
相關文獻
- A Study of FAPG Ointment Systems for Transdermal Delivery of Fluvastatin
- Evaluation of in Vitro Release Profiles of Developed Membrane-Moderated Transdermal Delivery Systems Containing Methylephedrine HCl
- Development and in Vitro Evaluation of Chitosan-based Transdermal Nicotine Delivery System
- Distribution of Free and Liposome-encapsulated Norfloxacin in Rat Skin Following Topical Administratin
- 以體外實驗法探討對鋁對鐵吸收之影響
- 鯨蠟醇對ketoprofen經皮吸收的影響
- 以體外實驗法評估中式黃豆加工食品中鐵之生體可用率
- A Preliminary Study of Osseointegration in the Dental Implant Therapy in vitro--Culture of Mouse KUSA/A1 Cells on Titanium Plates with Different Surface Modifications
頁籤選單縮合
題名 | A Study of FAPG Ointment Systems for Transdermal Delivery of Fluvastatin=脂肪醇與丙二醇混合基劑軟膏用於Fluvastatin經皮輸移之研究 |
---|---|
作者姓名(中文) | 王博駿; 游慧美; 許立人; 林恆弘; | 書刊名 | 嘉南學報. 科技類 |
卷期 | 30 民93.12 |
頁次 | 頁92-100 |
分類號 | 418.6342 |
關鍵詞 | 脂肪醇與丙二醇混合基劑軟膏; 經皮輸移; 大白鼠皮; 體外實驗; Fluvastatin; FAPG ointment; Transdermal delivery; Rat skin; In vitro; |
語文 | 英文(English) |
中文摘要 | Fluvastatin是用於臨床上脂質調節治療之第一個全合成HMG-Co A還原酶抑制劑,為了要達到並維持長時間在作用部位的適當治療濃度以增進治療效果,本研究嘗試使用脂肪醇與丙二醇混合基劑軟膏來發展經皮輸移系統,探討不同軟膏配方對軟膏黏稠度與所含藥物釋離的影響;其中軟膏的理化性質是以Cone and Plate黏度計來檢測,軟膏的理化性質對其所含藥物的釋離與經皮吸收的影響則以大白鼠皮的體外實驗來評估。結果指出,本軟膏是屬於假塑性流體且其藥物之釋離與軟膏之黏稠度呈反比的關係。在體外的藥物經皮穿透實驗中發現,fluvastatin的經皮輸移速率遠低於藥物自脂肪醇與丙二醇混合基劑軟膏的釋出速率。 |
英文摘要 | Fluvastatin is the first synthetic HMG-Co A reductase inhibitor to be approved for clinical lipid-modifying therapy. In order to achieve and maintain an adequate concentration of drug at the side of action for a prolonged period of time so as to improve the therapeutic efficiacy, in this work, we attempt to develop a transdermal delivery system by the use of FAPG ointment dosage forms. We investigated the effect of variation in the composition of ointments on the viscosity of ointments and drug release. The physicochemical properties of ointments were determined by Cone and Plate viscometer. The effect of ointment physicochemical properties on the release of fluvastatin from ointment bases and the percutaneous penetration through rat skin were discussed by in vitro studies. The results indicated that ointments are referred to as pseudoplastic flow and the increase in the drug release rate was inversely proportional to ointment viscosity. In in vitro permeation studies, the transdermal penetration rate of fluvastatin is much lower than the release rate of the drug from FAPG bases. It can be seen that fluvastatin cannot permeate through the rat skin in significant amount after application. The absorption enhancers were applied to increase the skin penetration of fluvastatin. Among the surfactants, the penetration efficiency of benzalkonium chloride and sodium lauryl sulfate were better than Tween 80 and Span 40. The concentration 1% of enhancers was found to be the most efficient in all case. Moreover, it did not show any significant difference in the penetration efficiency between to use the absorption enhancers to pretreat the skin before the application of ointment and to take absorption enhancers as additives to incorporate into FAPG ointments. The above results will be helpful to possible development of the other lipid-regulating drug transdermal delivery systems. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。